EXDI Exactus Inc

Exactus Announces the Promotion of Derek Du Chesne as Company President and appointment to the Board of Directors

Exactus Announces the Promotion of Derek Du Chesne as Company President and appointment to the Board of Directors

DELRAY BEACH, Fla., May 11, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading producer of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, announced today that the Company has promoted Derek Du Chesne to President.

In less than 3 months with Exactus and various accolades, the Company has promoted Derek Du Chesne to President and appointed him to the Board of Directors. Derek was initially brought on as Chief Growth Officer, where he implemented internal infrastructure systems designed to scale while developing additional income streams for Exactus.  Derek has utilized his vast connections within the food and beverage, pets, cosmetics, pharmaceutical industries and added immense value to Exactus.

Prior to joining Exactus, Derek was responsible for over $50MM in 2019 revenue and secured over $40 million in funding for his previous Company. He is a thought leader in the industry and has the expertise, vision and ability to create change.  Derek is an integral part of Exactus becoming the leading cultivator and manufacturer of hemp derived ingredients. Mr. Du Chesne is a brand management professional who has a proven track record of creating integrated marketing strategy platforms, through concept, development, and launch, as well as building iconic brands by orchestrating successful campaign deployment on both a global and regional scale.

“We are happy to announce the promotion of Derek Du Chesne as President and appointment to the Board of Directors of Exactus Inc., where he will take on more responsibility and continue to contribute to the growth and success of Exactus,” said Bobby Yampolsky, Exactus Chairman of the Board. “Derek has been a principal driving force in restructuring and organizing a strong team as well as securing funding and new investors.  His industry knowledge and market vision is exactly what our Company has needed to accomplish our goal of being a leader in the hemp industry. There are only a handful of executives in the world that hold these accolades in the hemp space and we are very happy to have him lead our company and guide us to the next phase of success.”

To learn more about Exactus, Inc., visit the website at .

About Exactus

Exactus Inc. (OTCQB: EXDI) is a leading producer and supplier of hemp-derived ingredients, and feminized hemp genetics.  Exactus is committed to creating a positive impact on society and the environment by promoting sustainable agricultural practices. Exactus specializes in hemp-derived ingredients (CBD/CBG/CBC/CBN) and feminized seeds that meet the highest standards of quality and traceability. Through research and development, the Company continues to stay ahead of market trends and regulations.  Exactus is at the forefront of product development for the beverage, food, pets, cosmetics, wellness, and pharmaceutical industries.

Safe Harbor - Forward-Looking Statements

The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "anticipates," "plans," "expects," "intends," "will," "potential," "hope" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company's periodic and current filings with the SEC, including the factors described in the sections entitled "Risk Factors", copies of which may be obtained from the SEC's website at Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Contact:

Andrew Johnson

Chief Strategy Officer

Exactus Inc.

PR Contact:

Kathleen Gonzales

EN
11/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactus Inc

 PRESS RELEASE

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Confer...

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call Second Quarter 2020 Highlights Total Net Revenue of $531,240Continuation of Sales & Marketing BuildoutWhite Label Division LaunchEuropean Sales ExpansionStrengthened the Balance Sheet DELRAY BEACH, Fla., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, reported its financial results for the second quarter 2020 and conference call dial-in information. During the second quarter of 2020, Exactus c...

 PRESS RELEASE

Exactus, Inc. Reports First Quarter 2020 Financial Results

Exactus, Inc. Reports First Quarter 2020 Financial Results First Quarter 2020 Highlights Total Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction ProcessDuring Q2 2020, The Company Received PPP Funds and an SBA Loan DELRAY BEACH, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, E...

 PRESS RELEASE

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of...

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors DELRAY BEACH, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chie...

 PRESS RELEASE

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impa...

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback progra...

 PRESS RELEASE

Exactus, Inc. Reports 2019 Year End Results

Exactus, Inc. Reports 2019 Year End Results Year End 2019 Highlights Completed first harvestEntered into multiple supply agreements with industry leadersBuilt a foundation for mainstream adoptionSolidified our footprint in the hemp industryDuring Q1 2020, purchase orders for approximately $900,000 of CBD and CBG products have been received. DELRAY BEACH, Fla., May 26, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the year end 2019. Duri...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch